Prioritize Advanced Therapies in Crohn Disease

March 2026

You’ll see more up-front use of advanced therapies in moderate to severe Crohn disease...due to updated guidelines.

We know that Crohn disease is a type of inflammatory bowel disease that leads to abdominal pain, diarrhea, etc.

Previous guidelines suggested early use of biologics, with or withOUT immunomodulators (azathioprine, etc).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote